Veterinary medicine has undergone a period of remarkable advancement in the last decade, with new pharmaceuticals transforming treatment protocols and improving patient outcomes. According to a Global Market Report, the veterinary medicine market will grow from $31.08 billion in 2024 to $33.29 billion in 2025. This rapid growth is fueled by innovative therapies and evolving treatment strategies and highlights the significance of veterinary pharmacology in ensuring animal health and well-being.
Veterinary pharmacology is essential for disease management, food safety, and improving the quality of life of companion animals and livestock. The increase in scientific research is transforming veterinary diagnostics and therapy through developing trends.
Related: Dispensing Veterinary Prescription Drugs: An Overview
Precision veterinary medicine
Precision (personalized) veterinary medicine has the potential to revolutionize the practice of medicine and improve treatment outcomes. By tailoring treatments to individual animals, veterinarians can achieve more accurate diagnoses and deliver targeted therapies.
Pharmacogenomics, the study of how genetic variations affect drug metabolism and response, is a key component of precision veterinary medicine. When prescribing medications, veterinarians must consider species-specific drug metabolism.
Genetic differences impact how animals process and eliminate medications, just as they do in humans. For example, cats have a limited capacity to metabolize certain drugs, such as acetaminophen, predisposing them to severe toxicity. Dogs with an MDR1 gene mutation may have severe and life-threatening reactions to some common drugs.
Recognizing and understanding these differences enables veterinarians to personalize treatment, choosing the most effective drugs and dosages to reduce the risk of adverse reactions or ineffective therapy.
The advantages of precision veterinary medicine are significant. Drugs are more effective, side effects are minimized, and overall treatment outcomes are significantly improved. These advancements, fueled by progress in veterinary pharmacology, pave the way for a future of more precise and tailored animal healthcare.
Nanotechnology in veterinary pharmacology
Nanotechnology is used to produce nanoscale drugs, controlled delivery systems, contaminant detection, and the design of molecular and cellular biology nanodevices. Some of veterinary medicine’s major nanotechnological approaches include the following:
Nanovaccines
Nanovaccines can stimulate both humoral and cell-mediated immune responses. In many cases, they are more effective than traditional vaccines. They have the promise of channeling the body’s immune system to combat pathogens and avoid the spread of infections and diseases.
With nanotechnology, vaccine adjuvants can be designed for reduced dose frequency and a comfortable route of administration to induce a particular target immune response. For example, the intranasal route improves target mucosal immunity.
Nanopharmaceuticals
Through nanotechnology, new veterinary drugs are being developed, and traditional medications are being reformulated for increased efficacy. Compared to administering free drugs, loading medications onto nanoparticles—using methods like physical encapsulation, adsorption, or chemical conjugation—can dramatically improve their pharmacokinetics and therapeutic index. This targeted approach offers significant advantages in drug delivery.
Several nano-drug delivery systems have shown the effectiveness of nanoparticles in enhancing pharmacokinetics, reducing unwanted side effects, and optimizing transmission to disease sites. Because the active agent is concentrated specifically in the diseased area, this method allows for the use of the necessary drug dosage while significantly minimizing side effects.
Nanoparticulate drug carriers enhance drug solubility and safety, increase the circulation time of medications, minimize adverse effects in non-target organs, and achieve targeted drug delivery to the site of disease.
Complete your Veterinary CE online
Animal breeding and reproduction
Researchers are applying nanotechnology to advance animal reproduction. Several key areas:
- Characterizing gamete cells with advanced microscopy
- Developing nanosensors for reproductive status detection
- Exploring metal nanoparticles for fertility control
- Improving cryopreservation with nanodevices
- Creating sustained-release systems for a range of molecules, including hormones, vitamins, antibiotics, antioxidants, and nucleic acids
Nanotechnology offers a range of powerful tools, including microfluidics, nanoparticles, and bioanalytic nanosensors. These can be applied to solve complex problems related to animal health, growth, reproduction, and disease.
Disease diagnostics
Functional molecular imaging offers a powerful tool for early disease detection. By using non-invasive and specific modalities, it provides in vivo anatomical and physiological information. This allows for the identification of molecular changes before they become visible through traditional methods.
Unlike Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), which focus on anatomical structure, Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) are nuclear medicine imaging techniques that reveal metabolic and functional processes. However, the true power of these techniques is realized when SPECT or PET is combined with CT or MRI. This combined approach allows for the simultaneous visualization of both detailed anatomy and vital metabolic/functional information.
Cancer treatment and diagnosis
A major challenge in cancer treatment is the toxicity associated with traditional chemotherapy. These drugs indiscriminately target both cancerous and healthy cells. Researchers are actively seeking ways to overcome this challenge by developing targeted therapies that can effectively eliminate cancer cells without harming healthy tissues.
Nanotechnology is revolutionizing drug delivery by creating devices, including complex submicron nanoparticles, that can precisely target medications to various sites in the body.
Nanoparticles hold great promise for cancer therapy due to their unique properties. Their high surface-to-volume ratio allows for the attachment of targeting molecules, enabling selective binding to tumor cells. Their small size (10-100 nm) promotes accumulation in tumors due to poor lymphatic drainage. These characteristics pave the way for creating multifunctional nanoparticles capable of diagnosing, imaging, and treating tumors.
Immunopharmacology
Immunopharmacology, or the examination of the effects of pharmaceuticals on the immune system, is an expanding discipline of considerable importance to veterinary medicine. It investigates the complex interactions between pharmaceuticals and the immune system, presenting novel opportunities for the treatment of various animal diseases. The field is essential for understanding the mechanisms by which the immune system can be manipulated to combat diseases and enhance animal health.
Immunomodulators are agents that possess the capacity to either enhance or inhibit the immune response. In veterinary medicine, these interventions boost a compromised immune system or to mitigate an excessively active one. For example, immunomodulators may be used to help animals in combating infections or to regulate autoimmune disorders.
Targeted immunotherapy offers a more precise treatment strategy by designing therapies that focus on specific immune system components involved in disease. This method is especially effective in cancer treatment, where the aim is to activate the immune system to identify and eliminate tumor cells.
Several immunopharmacological methods are already in use in veterinary practice. Cytokines, which are signaling molecules that regulate immune responses, are sometimes administered to stimulate the immune system in animals with infections or cancer. Monoclonal antibodies, highly specific antibodies created to target a particular antigen, are also being utilized to treat specific conditions in animals, such as allergic dermatitis and atopic dermatitis in dogs.
Antimicrobial resistance
Antimicrobial resistance (AMR) is a growing threat in veterinary medicine, driven by antibiotic misuse and overuse. The WHO warns of widespread treatment failure if AMR continues to rise. Combating this requires responsible antibiotic use by veterinarians, including careful selection, dosage, and prescribing only when necessary. Alternative therapies like bacteriophages, antimicrobial peptides, and probiotics are being explored. Ongoing research aims to develop new treatments, combining traditional and emerging therapies to combat resistant infections effectively.
Veterinary pharmacology is rapidly evolving, driven by innovations like precision medicine, nanotechnology, immunopharmacology, and antimicrobial resistance strategies. These advancements promise more effective, targeted therapies with fewer side effects. In turn, these will lead to more precise, efficient, and sustainable animal healthcare.
Veterinarians must embrace these developments to optimize patient care. The future of the field lies in integrating traditional and emerging therapies to ensure animal health and well-being.
References
- The Business Research Company. (2024). Veterinary medicine global market report. Retrieved from https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report
- Assadi P (2008) A novel multiplication algorithm in nanotechnology. J Appl Sci 8: 2625-2630.10.3923/jas.2008.2625.2630
- Woldeamanuel KM, Kurra FA, Roba YT (2021) A review on nanotechnology and its application in modern veterinary science. Int J Nanomater Nanotechnol Nanomed 7(1): 026-031. DOI: https://dx.doi.org/10.17352/2455-3492.000041
- Zhang L, Pornpattananangku D, Hu CM, Huang CM. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem. 2010;17(6):585-94. doi: 10.2174/092986710790416290. PMID: 20015030.
- McMillan J, Batrakova E, Gendelman HE. Cell delivery of therapeutic nanoparticles. Prog Mol Biol Transl Sci. 2011;104:563-601. doi: 10.1016/B978-0-12-416020-0.00014-0. PMID: 22093229; PMCID: PMC4016803.
- Patil, S., Kore, K., & Kumar, P. (2009). Nanotechnology and its applications in veterinary and animal science. Veterinary World, 2(1), 475-477. https://doi.org/10.5455/vetworld.2009.475-477
- Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng. 2007;9:257-88. doi: 10.1146/annurev.bioeng.9.060906.152025. PMID: 17439359.
- Regan, D., & Dow, S. (2015). Manipulation of Innate Immunity for Cancer Therapy in Dogs. Veterinary Sciences, 2(4), 423-439. https://doi.org/10.3390/vetsci2040423
